Plegridy(TM) marketing applications accepted for review

A board to discuss the Multiple Sclerosis modifying drug Plegridy

Plegridy(TM) marketing applications accepted for review

Postby MSUK » Mon Jul 22, 2013 6:56 am

US and EU regulatory authorities accept Plegridy(TM) (peginterferon beta-1a) marketing applications for review

Biogen Idec announced that U.S. and EU regulatory authorities have accepted the marketing applications for the review of Plegridy(TM) (peginterferon beta-1a), the company's pegylated subcutaneous injectable candidate for relapsing forms of multiple sclerosis (MS). The U.S. Food and Drug Administration (FDA) has accepted Biogen Idec's Biologics License Application (BLA) for marketing approval of PLEGRIDY in the United States and granted the company a standard review timeline. The Marketing Authorisation Application (MAA) of Plegridy for review in the European Union was also validated by the European Medicines Agency...... Read More -
User avatar
Family Elder
Posts: 2903
Joined: Wed Oct 14, 2009 2:00 pm


Return to Plegridy


  • Related topics
    Last post

Who is online

Users browsing this forum: No registered users

Contact us | Terms of Service